A urinary biomarker
Related Products
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Hexanoyl Glycine

Item No. 16412

Technical Information
Formal Name
N-1-oxohexyl-glycine
CAS Number
24003-67-6
Synonyms
  • NSC 224460
Molecular Formula
C8H15NO3
Formula Weight
Purity
≥95%
A crystalline solid
DMF: 50 mg/mlDMSO: 30 mg/mlEthanol: 50 mg/mlPBS (pH 7.2): 5 mg/ml
SMILES
OC(CNC(CCCCC)=O)=O
InChi Code
InChI=1S/C8H15NO3/c1-2-3-4-5-7(10)9-6-8(11)12/h2-6H2,1H3,(H,9,10)(H,11,12)
InChi Key
UPCKIPHSXMXJOX-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Hexanoyl glycine is an acylated amino acid that is used as a urinary biomarker for several indications. It is normally biosynthesized from hexanoyl-CoA and glycine by the mitochondrial enzyme glycine N-acyltransferase. Increased urinary excretion of hexanoyl glycine in humans is indicative of a deficiency in medium-chain acyl-CoA dehydrogenase.1,2 Increased urinary hexanoyl glycine can also be used as a biomarker for exposure to gamma radiation.3 Levels of hexanyl glycine can also be elevated during cancer, while they are decreased 20-fold in mice following treatment with the PPARα ligand Wy 14643 (Item No. 70730).4,5

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Rinaldo, P., O'Shea, J.J., Coates, P.M., et alMedium-chain acyl-CoA dehydrogenase deficiency. Diagnosis by stable-isotope dilution measurement of urinary n-hexanoylglycine and 3-phenylpropionylglycine. N. Engl. J. Med. 319(20), 1308-1313 (1988).

    2. Tserng, K.Y., Jin, S.J., Kerr, D.S., et alAbnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency. J. Lipid Res. 31(5), 763-761 (1990).

    3. Tyburski, J.B., Patterson, A.D., Krausz, K.W., et alRadiation metabolomics: Identification of minimally invasive urine biomarkers for gamma-radiation exposure in mice. Radiat. Res. 170(1), 1-14 (2008).

    4. Li, F., Patterson, A.D., Krausz, K.W., et alMetabolomics reveals that tumor xenografts induce liver dysfunction. Mol. Cell. Proteomics 12(8), 2126-2135 (2013).

    5. Zhen, Y., Krausz, K.W., Chen, C., et alMetabolomic and genetic analysis of biomarkers for PPARα expression and activation. Mol. Endocrinol. 21(9), 2136-2151 (2007).